Application protocol

Viral transduction of human hematopoietic stem cells (HSC)

In this application protocol, we describe the viral transduction of human HSCs isolated from various sources, their concomitant expansion in defined cell culture conditions, and analysis of their function using flow cytometry or colony-forming assays. 

Materials

The following is a listing of reagents, instruments, and consumables needed for each step of this protocol. These products are for research use only.

For mononuclear cell isolation

  • PE buffer: phosphate buffered saline (PBS), pH 7.2, and 2mM EDTA. Keep buffer cold (2–8 °C).
  • 15 mL of Ficoll-Paque™ (ρ = 1.077 g/mL)
  • MACS® SmartStrainers (100 µm) (# 130-098-463)

For CD34+ cell isolation

  • CD34 MicroBead Kit UltraPure, human (# 130-100-453)
  • MC CD34 Stem Cell Cocktail (# 130-093-427) for flow cytometry analysis of separated cells. 
  • (Optional) Fluorochrome-conjugated antibodies for flow cytometry analysis, e.g., CD34-FITC (# 130-081-001), CD34-PE (# 130-081-002), CD34-APC (# 130-090-954), CD133 (293C3)-PE (# 130-090-853), CD133 (293C3)-PE (# 130-090-854), CD45-FITC (# 130-080-202), CD45-PE (# 130-080-201), or CD45-APC (# 130-091-230). For more information about antibodies refer to www.miltenyibiotec.com/antibodies.
  • (Optional) Propidium Iodide Solution (# 130-093-233) or 7-AAD for flow cytometric exclusion of dead cells.
  • (Optional) Dead Cell Removal Kit (# 130-090-101) for the depletion of dead cells.
  • (Optional) Pre-Separation Filters, 30 µm (# 130-041-407) to remove cell clumps.
  • PBE buffer: Prepare a solution containing phosphate-buffered saline (PBS), pH 7.2, 0.5 % bovine serum albumin (BSA), and 2 mM EDTA by diluting MACS BSA Stock Solution (# 130-091-376) 1:20 with autoMACS® Rinsing Solution (# 130-091-222). Keep buffer cold (2−8 °C). Degas buffer before use, as air bubble could block the column.
    Note: EDTA can be replaced by other supplements such as anticoagulant citrate dextrose formula-A (ACD-A) or citrate phosphate dextrose (CPD). BSA can be replaced by other proteins such as human serum albumin, human serum, or fetal bovine serum (FBS). Buffers or media containing Ca2+ or Mg2+ are not recommended for use.
  • MACS Columns and MACS Separators: CD34+ cells can be enriched by using MS, LS, or XS Columns (positive selection). Cells that strongly express the CD34 antigen can also be depleted using MS, LS, or XS Columns.
    ▲ Note: Positive selection or depletion can also be automated using the autoMACS Pro or the autoMACS Separator.
ColumnMax. number of labeled cellsMax. number of total cellsSeparator
Positive or negative selection
MS1×1072×10⁸MiniMACS™, OctoMACS™,
VarioMACS, SuperMACS II
LS1×1082×109MidiMACS™, QuadroMACS™,
VarioMACS, SuperMACS II
XS1×1092×1010SuperMACS II
Positive or negative selection
autoMACS2×1084×109autoMACS Pro, autoMACS
Note: Column adapters are required to insert certain columns into the VarioMACS™ or SuperMACS™ II Separators. For details refer to the respective MACS Separator data sheet.

For viral transduction

  • Vectofusin-1® (# 130-111-163)
  • Culture medium for transduction without serum or lipids, e.g., IMDM or RPMI
  • StemMACS™ HSC Expansion Media XF, human (# 130-100-463)
  • StemMACS HSC Expansion Cocktail (# 130-100-843)

For CD34+ cell expansion

  • StemMACS HSC Expansion Media XF, human (# 130-100-463)
  • StemMACS HSC Expansion Cocktail (# 130-100-843)

Cytokines included in the StemMACS HSC Expansion Cocktail:

  • Human SCF (# 130-096-693)
  • Human FLT3-Ligand (# 130-096-476)
  • Human Thrombopoietin (TPO) (# 130-094-011)

For flow cytometry analysis

  • StemMACS HSC-CFU complete with Epo, human (# 130-091-280)
  • CD45-VioBlue, human  (# 130-092-880)
  • CD45RA-FITC, human  (# 130-092-247)
  • CD133/2 (293C3)-PE, human (# 130-090-853)
  • CD34-APC, human (# 130-090-954)
Matching products:

Protocol


View timeline

This protocol includes detailed instructions for preparing necessary reagents and materials and then carrying out each step.

Preparation of buffers for cell isolation

PE buffer for isolation of mononuclear cells

Prepare a solution with phosphate buffered saline (PBS), pH 7.2, and 2mM EDTA. Keep buffer cold (2–8 °C).
▲ Note: EDTA can be replaced by other supplements such as anticoagulant citrate dextrose formula-A (ACD-A) or citrate phosphate dextrose (CPD).

PBE buffer for isolation of CD34+ cells

Prepare a solution containing phosphate-buffered saline (PBS), pH 7.2, 0.5 % bovine serum albumin (BSA), and 2  mM EDTA by diluting MACS® BSA Stock Solution 1:20 with autoMACS® Rinsing Solution. Keep buffer cold (2−8 °C).
▲ Note: EDTA can be replaced by other supplements such as anticoagulant citrate dextrose formula-A (ACD-A) or citrate phosphate dextrose (CPD). BSA can be replaced by other proteins such as respective serum albumin, respective serum, or fetal bovine serum (FBS). Buffers or media containing Ca2+ or Mg2+
are not recommended for use.

Isolate mononuclear cells by density gradient centrifugation using Ficoll-Plaque™. Follow the Ficoll-Plaque™ protocol from the data sheet corresponding to the source tissue.

Download data sheet

Isolation of mononuclear cells from human peripheral blood

Isolation of mononuclear cells from bone marrow aspirates

Isolation of mononuclear cells from cord blood

Isolate CD34+ cells among the mononuclear cells using the CD34 MicroBead Kit UltraPure, human and LS or MS columns. Follow the protocol of the kit data sheet.

We recommend filtering the magnetically labeled cell suspension before separation on the column to guarantee a single-cell suspension.

  1. Place a Pre-Separation filter (30 µm) on the separation column.
  2. Rinse the column three times with PBE buffer, pre-wetting the filter.
  3. Apply the cell suspension and the washing buffer to the filter on the column.

Download kit data sheet

CD34 MicroBead Kit UltraPure, human

View details

High purity CD34+ cells isolated from a PBMC sample using the CD34 MicroBead Kit UltraPure.  CD34+ cells were isolated from a debris-rich PBMC  sample using the CD34 MicroBead Kit UltraPure, two MS Columns, and a MiniMACS™  Separator. Cells were stained with CD34-PE, CD45-FITC and propidium iodide. Cells were analyzed  after gating on propidium iodide, lymphoid cells.

View details

Reduced debris carry-over during CD34+ cell isolation. A comparison of the ungated forward scatter versus side scatter profile of the same sample after separation with the CD34 MicroBead Kit or the CD34 MicroBead Kit UltraPure demonstrates reduced debris carry-over with the CD34 MicroBead Kit UltraPure.

Isolated CD34+ cells can be transduced using retroviral or lentiviral vectors. Perform transduction either directly after enrichment or after pre-stimulation culture in StemMACS™ HSC Expansion Media XF supplemented with StemMACS HSC Expansion Cocktail.

Use Vectofusion-1®, a novel transduction enhancer, to boost transduction efficiency. Follow the protocol of the data sheet.

Download data sheet

Vectofusion-1

For expansion, culture the isolated CD34+ cells in StemMACS™ HSC Expansion Media XF supplemented with StemMACS HSC Expansion Cocktail. Follow the protocol of the media data sheet.

Download data sheet

StemMACS HSC Expansion Media XF, human

View details

High levels of CD34+ cells. Cryopreserved CD34+ cells separated from cord blood were expanded for 7 days in the indicated media supplemented with StemMACS HSC Expansion Cocktail (n=4; mean +/– SD). Values were normalized to StemMACS HSC Expansion Media XF.  StemMACS HSC Expansion Media XF consistently maintains high levels of CD34+ cells during expansion.

Analyze the expanded CD34+ cells for HSC-specific surface markers via flow cytometry using REAfinity™ antibodies, or perform CFU-GEMM analysis to assess their myeloid differentiation potential. 

View details

Preserved HSC surface phenotype.  CD34+ cord blood cells were expanded for 7 days in StemMACS™ HSC Expansion Media XF (red) or alternative media (blue) supplemented with StemMACS HSC Expansion Cocktail. The cell surface phenotype was assessed by flow cytometry. Cells expanded in StemMACS HSC Expansion Media XF maintain the characteristic surface phenotype of early 
hematopoietic progenitors and typically show a higher proportion of phenotypically primitive cells.

View details

Preserved broad differentiation potential.  Isolated CD34+ cord blood cells were expanded in the indicated media plus StemMACS HSC Expansion Cocktail. After 7 days, cells were analyzed for their CFU potential. Cells cultured in StemMACS HSC Expansion Media XF maintained broad hematopoietic differentiation potential, giving rise to all major CFU types, including primitive CFU-GEMMs.

Unless otherwise specifically indicated, Miltenyi Biotec products and services are for research use only and not for therapeutic or diagnostic use.

autoMACS, CliniMACS, the CliniMACS logo, CliniMACS Prodigy, CryoMACS, CytoMix, CytoStim, DendriMACS, ExiTron, ExpAct, FeraSpin, FeraTrack, GadoSpin, gentleMACS, LIFE 18, LIFE 21, MACS, the MACS logo, MACSductin, MACSelect, MACSfectin, MACSflex, MACSiBead, MACSiMAG, MACSmix, MACSprep, MACSQuant, MACSQuantify, MACSxpress, MidiMACS, MiniMACS, miRXplore, MultiMACS, NeuroBrew, NiraWave, OctoMACS, PepTivator, pMACS, PolySon, PrepProtect, QuadroMACS, REAfinity, REAlease, Rheo, StemMACS, StraightFrom, SuperAmp, SuperMACS, TexMACS, TheraSorb, thermoMACS, TransAct, Tyto, the Tyto logo, VarioMACS, Vio, Viobility, VioBlue, VioBright, VioGreen, Viscover, and µMACS are registered trademarks or trademarks of Miltenyi Biotec GmbH and/or its affiliates in various countries worldwide. Ficoll-Paque is a trademark of GE Healthcare companies. Vectofusin-1 is a registered trademark of Genethon. All other trademarks mentioned in this document are the property of their respective owners and are used for identification purposes only. Copyright © 2018 Miltenyi Biotec GmbH and/or its affiliates. All rights reserved.